With the latest Center for Drug Evaluation (CDE) announcement that eCTD will become mandatory across China in 2018, it is vital that EXTEDO’s customers have the best possible local support. “Besides our own office in Shanghai and our successful partnership with Neotrident China, our new partnership with Taimei Medical is another important milestone on the road to fulfilling the complex market requirements in China”, said Martin Schmid, CEO at EXTEDO.
Taimei will support EXTEDO’s solutions in the capacity of a Professional Partner. They will promote EXTEDO’s solutions in China and will provide professional technical, consulting and implementation services for local Life Sciences customers.
“Together with our partners, EXTEDO will be able to address the needs of Life Science organizations within the country and deliver the necessary software, solutions, and services designed to help streamline the registration process for pharmaceutical products. EXTEDO is proud to add Taimei to our portfolio of leading partnerships”, said Christian Bohrmann, VP Marketing & Alliances at EXTEDO.
About Jiaxing Taimei Medical Technology
Taimei comes with extensive experience, collaborating with over 200 local and global life science companies and CROs to meet the increasingly complicated regulatory requirements in China. This is made possible by a multidisciplinary team of 300 employees, 40% of whom with solid working experience within the healthcare industry. Taimei provides high-quality professional services based on innovative technologies that reduce human labor and enhance efficiency, with the aim of helping clients optimize their value across life science product lifecycles.
EXTEDO is a leading solutions and services provider in the field of Regulatory Information Management (RIM). We focus on optimizing our clients‘ eRegulatory business processes and are the only vendor that provides solutions covering the entire regulatory landscape. Our EXTEDOsuite combines innovation with compliance, and quality with usability.
Whether planning & tracking, product registration, submission publishing and lifecycle management, pharmacovigilance management and drug safety; we optimize every eRegulatory business process. Today, EXTEDO enables more than 35 regulatory authorities and over 700 maintained customers across 60 countries to deliver Effortless Compliance™.
For more information, visit www.extedo.com.
EXTEDO GmbH
Einsteinstrasse 30
85521 Ottobrunn
Telefon: +49 (89) 189454-0
Telefax: +49 (89) 189454-999
http://www.extedo.com
Global Marketing Manager
Telefon: +49 (89) 189454222
E-Mail: kessler@extedo.com